XAAV Trademark

Trademark Overview


On Monday, February 28, 2022, a trademark application was filed for XAAV with the United States Patent and Trademark Office. The USPTO has given the XAAV trademark a serial number of 79342692. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 30, 2023. This trademark is owned by Oxford Genetics Ltd. The XAAV trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use; none of the aforesaid being or including cell growth media

Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes; none of the aforesaid being or including cell growth media

Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services; none of the aforesaid services relating to cell growth media
xaav

General Information


Serial Number79342692
Word MarkXAAV
Filing DateMonday, February 28, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use; none of the aforesaid being or including cell growth media
Goods and ServicesChemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes; none of the aforesaid being or including cell growth media
Goods and ServicesDesign services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services; none of the aforesaid services relating to cell growth media

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxford Genetics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, June 16, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 21, 2022APPLICATION FILING RECEIPT MAILED
Saturday, November 19, 2022LIMITATION OF GOODS RECEIVED FROM IB
Saturday, December 3, 2022LIMITATION OF GOODS RECEIVED FROM IB
Monday, December 12, 2022ASSIGNED TO EXAMINER
Friday, December 16, 2022NON-FINAL ACTION WRITTEN
Saturday, December 17, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 12, 2023LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Thursday, January 12, 2023LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, February 13, 2023REFUSAL PROCESSED BY MPU
Monday, February 13, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 6, 2023REFUSAL PROCESSED BY IB
Wednesday, August 30, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 30, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, August 31, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, November 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, December 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, August 31, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, September 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 20, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 8, 2024NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, November 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB